Sharp took over operations at the 146,000-square-foot plant and is now packaging several of Daiichi’s medications. Sharp said it has offered the plant’s workers opportunities for employment.

"The ASCO meeting presentations ... under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo research and development is primarily ...